Accessibility Menu
Ventripoint Diagnostics logo

Ventripoint Diagnostics

(TSXV) VPT

Current PriceCA$0.12
Market CapCA$23.11M
Since IPO (2007)-97%
5 Year-68%
1 Year+4%
1 Month-23%

Ventripoint Diagnostics Financials at a Glance

Market Cap

CA$23.11M

Revenue (TTM)

CA$179.93K

Net Income (TTM)

-CA$3.20M

EPS (TTM)

-CA$0.02

P/E Ratio

-6.19

Dividend

CA$0.00

Beta (Volatility)

0.05 (Low)

Price

CA$0.12

Volume

53,005

Open

CA$0.12

Previous Close

CA$0.12

Daily Range

CA$0.12 - CA$0.12

52-Week Range

CA$0.08 - CA$0.19

Estimated Earnings Date

Jun 11, 2026

VPT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ventripoint Diagnostics

Industry

Healthcare Equipment and Supplies

CEO

Hugh MacNaught

Headquarters

Toronto, ON M6P 1T4, CA

VPT Financials

Key Financial Metrics (TTM)

Gross Margin

83%

Operating Margin

-19%

Net Income Margin

-18%

Return on Equity

0%

Return on Capital

85%

Return on Assets

-7%

Earnings Yield

-16.16%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$23.11M

Shares Outstanding

192.58M

Volume

53.01K

Avg. Volume

145.38K

Financials (TTM)

Gross Profit

CA$118.69K

Operating Income

-CA$3.40M

EBITDA

-CA$3.34M

Operating Cash Flow

-CA$1.55M

Capital Expenditure

CA$0.00

Free Cash Flow

-CA$1.55M

Cash & ST Invst.

CA$55.39K

Total Debt

CA$2.60M

Ventripoint Diagnostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

CA$4.30K

N/A

Gross Profit

-CA$11.13K

+27.9%

Gross Margin

-2.59%

N/A

Market Cap

CA$23.11M

N/A

Market Cap/Employee

CA$2.31M

N/A

Employees

10

N/A

Net Income

-CA$199.75K

+81.1%

EBITDA

-CA$723.17K

+31.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

CA$55.39K

-8.5%

Total Debt

CA$2.60M

+59.1%

Accounts Receivable

CA$132.99K

-47.1%

Inventory

CA$0.00

N/A

Long Term Debt

CA$115.37K

-45.7%

Short Term Debt

CA$2.49M

+74.8%

Return on Assets

-6.78%

N/A

Return on Invested Capital

84.96%

N/A

Free Cash Flow

-CA$599.37K

+16.8%

Operating Cash Flow

-CA$599.37K

+16.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ASG.VAurora Spine Corporation
CA$0.23+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
LYGLloyds Banking Group Plc
$5.42+0.05%
NVDANvidia
$205.03+0.02%
CPNGCoupang
$17.32+0.15%
NOKNokia
$14.09+0.05%

Questions About VPT

What is the current price of Ventripoint Diagnostics?

Ventripoint Diagnostics is trading at CA$0.12 per share.

What is the 52-week range for Ventripoint Diagnostics?

Over the past 52 weeks, Ventripoint Diagnostics has traded between CA$0.08 and CA$0.19.

How much debt does Ventripoint Diagnostics have?

As of the most recent reporting period, Ventripoint Diagnostics reported total debt of CA$2.60M.

How much cash does Ventripoint Diagnostics have on hand?

Ventripoint Diagnostics reported CA$55.39K in cash and cash equivalents in its most recent financial results.

What is Ventripoint Diagnostics’s dividend yield?

Ventripoint Diagnostics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.